Elixi, Author at Elixi International - Page 12 of 13

27 April 2019

FDA approves Benlysta (belimumab) first treatment for pediatric patients with lupus

0 Comments3 Minutes

17 April 2019

Bristol-Myers Squibb Announces Long-Term Survival Results from Pooled Analyses of Opdivo (nivolumab) in Previously-Treated Non-Small Cell Lung Cancer Patients

0 Comments9 Minutes

9 April 2019

Dovato (dolutegravir and lamivudine), a new complete regimen for HIV-infected patients who have never received antiretroviral treatment

0 Comments5 Minutes

3 April 2019

Mayzent (siponimod) tablets approved by FDA to treat adults with relapsing forms of multiple sclerosis (MS)

0 Comments5 Minutes

2 April 2019

Zynteglo, New gene therapy to treat rare inherited blood condition

0 Comments4 Minutes

1 April 2019

Merck has announced the FDA approval of its Mavenclad (cladribine) tablets in various forms of multiple sclerosis (MS).

0 Comments5 Minutes

12 March 2019

FDA approves new nasal spray medication for treatment-resistant depression; available only at a certified doctor’s office or clinic

0 Comments6 Minutes

4 March 2019

New indication for Dupixent (dupilumab) as add on treatment for patients with severe asthma

0 Comments3 Minutes

4 March 2019

Ondexxya (andexanet alfa), first antidote for reversal of anticoagulation with factor Xa inhibitors apixaban and rivaroxaban

0 Comments3 Minutes

4 March 2019

Waylivra (volanesorsen), first treatment for rare disease characterised by high levels of triglycerides in blood

0 Comments3 Minutes